Today: 19 May 2026
Lam Research stock jumps 7% as Evercore lifts target ahead of earnings

Lam Research stock jumps 7% as Evercore lifts target ahead of earnings

New York, Jan 27, 2026, 18:15 EST — After-hours

  • Lam Research shares jumped roughly 7% on Tuesday, pushing the price to $238.46
  • Evercore ISI boosted its price target to $241 from $170, maintaining an Outperform rating
  • With Lam’s quarterly results due Wednesday after the bell, investors are adjusting their positions ahead of the announcement

Lam Research shares climbed roughly 7% on Tuesday, closing at $238.46 after hitting an intraday peak of $239.72. After-hours trading showed little movement in the stock.

This matters as Lam is set to report quarterly results on Wednesday, with its guidance often shifting sentiment across chipmaking equipment stocks. Investors react swiftly, repricing the sector at any sign of changes in factory spending.

Lam, a key player in wafer-fab equipment—the gear that etches and deposits ultra-thin layers on silicon wafers to make chips—plans to host its quarterly earnings call at 5:00 p.m. Eastern this Wednesday, the company announced.

Evercore ISI lifted its price target on Lam to $241 from $170, keeping its Outperform rating intact, MT Newswires reported Monday. The “Outperform” tag signals the broker expects the stock to outpace the broader market or competitors in its sector. MarketScreener

The rally wasn’t just a one-off. Applied Materials jumped roughly 4.1%, KLA climbed around 4.8%, and ASML’s U.S.-listed shares added about 2.9% in the latest session, highlighting widespread strength among semiconductor-capital-equipment stocks.

Traders will focus on any shifts in Lam’s view on orders from memory and foundry clients, especially if AI-driven demand is boosting steady tool shipments. It’s the guidance, more than the recent quarter, that usually shapes sentiment.

Part of it boils down to positioning. Lam has long served as a high-beta play on chip capacity spending expectations, meaning its stock can swing dramatically around earnings.

That said, the situation works both ways. If management signals caution about short-term demand or hints at postponed customer spending, the stock could quickly lose its gains—especially since the sector tends to move in sync.

Wednesday’s earnings report and outlook will be the next key trigger. Investors are also eyeing updates from other chip-equipment firms this week, with ASML’s results set for January 28.

Stock Market Today

  • New 2024 Legislation Challenges Traditional 6% Real Estate Commissions
    May 19, 2026, 6:12 AM EDT. In 2024, new legislation aims to disrupt the standard 6% commission model in real estate sales. This change targets commissions on high-value properties like a $1 million Maui home. Sellers may see reduced agent fees as the law encourages more competitive pricing structures, potentially saving thousands of dollars. The shift reflects increasing pressure on traditional real estate agents to adjust their commission rates in a changing market landscape.

Latest articles

Hesai Stock Rises Before the Bell as Mercedes Lidar Deal Meets Q1 Profit

Hesai Stock Rises Before the Bell as Mercedes Lidar Deal Meets Q1 Profit

19 May 2026
Hesai Group shares rose 2.68% to $22.60 in U.S. premarket trading after reporting a first-quarter profit and confirming it will supply lidar sensors for Mercedes-Benz Level 3 autonomous models. The company shipped 471,723 lidar units, up 140.9% year-on-year, and posted revenue of RMB680.6 million ($98.7 million). Net income reached RMB18.3 million, reversing a loss from a year earlier.
Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.

Popular

Figma shares test rebound as AI bet delivers

Figma shares test rebound as AI bet delivers

18 May 2026
Figma traded at $23.20 Monday afternoon, valuing the company at $12.1 billion. First-quarter revenue jumped 46% to $333.4 million, and the company raised its 2026 revenue forecast to up to $1.428 billion. Paid customers rose 54% to about 690,000. Figma posted a GAAP net loss of $142.4 million but reported $56.5 million in non-GAAP net income.
Oracle stock slides 4% as AI spending scrutiny builds ahead of Fed decision
Previous Story

Oracle stock slides 4% as AI spending scrutiny builds ahead of Fed decision

Carvana stock rises after Wells Fargo target hike, but options traders lean defensive
Next Story

Carvana stock rises after Wells Fargo target hike, but options traders lean defensive

Go toTop